王麗鈴醫師
引用
醫師個人簡介
主治專長
合併放射化學治療、婦癌放射治療及近接治療、食道癌放射治療、強度調控放射治療、弧形調控放射治療、影像導引放射治療、一般癌症放射治療。
Concurrent chemoradiotherapy
Radiotherapy and brachytherapy for gynecologic cancers.
Radiotherapy for esophageal cancer.
IMRT, arc therapy, IGRT.
Radiotherapy for various types of cancer.
Concurrent chemoradiotherapy
Radiotherapy and brachytherapy for gynecologic cancers.
Radiotherapy for esophageal cancer.
IMRT, arc therapy, IGRT.
Radiotherapy for various types of cancer.
專業經驗
放射腫瘤科主治醫師
婦癌同步化學放射治療及近接治療
婦癌同步化學放射治療及近接治療
重要經歷/進修訓練
台中榮民總醫院放射腫瘤科住院醫師、總醫師、主治醫師。
學歷
台北醫學大學醫學系畢業
專科證照
放射腫瘤科專科醫師
台灣放射腫瘤學會
中華民國放射線醫學會
中華民國癌症醫學會
台灣放射腫瘤學會
中華民國放射線醫學會
中華民國癌症醫學會
教師資格
國防大學醫學院臨床教授
研究興趣
婦癌、子宮頸癌、子宮內膜癌
代表作
1. Hsieh HY, Huang JW, Lu CH, Lin JC, Wang L. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy. J Formos Med Assoc 2019;118(1 Pt 1):99-108. (SCI)
2. Hsieh HY, Wang L, Lu CH, Lin JC, Chen CC. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients. J Formos Med Assoc 2018;117(7):613-620. (SCI)
3. Kuang-Cheng Yin, Chien-Hsing Lu, Jin-Ching Lin, Chiann-Yi Hsu, Lily Wang. Treatment outcomes of locally advanced cervical cancer by histopathological types in a single institution: A propensity score matching study. J Formos Med Assoc 2018;117(10):922-931. (SCI)
4. Chien-Chih Chen, Lily Wang, Jin-Ching Lin, Jian-Sheng Jan. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy. J Formos Med Asso 2015;114(3):231-237. (SCI)
5. Chien-Chih Chen, Lily Wang, Chien-Hsing Lu, Jin-Ching Lin, Jian-Sheng Jan. Comparison of clinical outcomes and toxicity in endometrial cancer patients treated with adjuvant intensity-modulated radiation therapy or conventional radiotherapy. J Formos Med Assoc 2014;113(12):949-955. (SCI)
6. Chien-Chih Chen, Jin-Ching Lin, Jian-Sheng Jan, Shih-Chu Ho, Lily Wang. Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer. Gynecol Oncol 2011;122(1):9-13. (SCI)
2. Hsieh HY, Wang L, Lu CH, Lin JC, Chen CC. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients. J Formos Med Assoc 2018;117(7):613-620. (SCI)
3. Kuang-Cheng Yin, Chien-Hsing Lu, Jin-Ching Lin, Chiann-Yi Hsu, Lily Wang. Treatment outcomes of locally advanced cervical cancer by histopathological types in a single institution: A propensity score matching study. J Formos Med Assoc 2018;117(10):922-931. (SCI)
4. Chien-Chih Chen, Lily Wang, Jin-Ching Lin, Jian-Sheng Jan. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy. J Formos Med Asso 2015;114(3):231-237. (SCI)
5. Chien-Chih Chen, Lily Wang, Chien-Hsing Lu, Jin-Ching Lin, Jian-Sheng Jan. Comparison of clinical outcomes and toxicity in endometrial cancer patients treated with adjuvant intensity-modulated radiation therapy or conventional radiotherapy. J Formos Med Assoc 2014;113(12):949-955. (SCI)
6. Chien-Chih Chen, Jin-Ching Lin, Jian-Sheng Jan, Shih-Chu Ho, Lily Wang. Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer. Gynecol Oncol 2011;122(1):9-13. (SCI)